Works by Desar, I. M. E.
Results: 8
Double burden: financial toxicity in patients with advanced soft tissue sarcoma at the start of first-line palliative chemotherapy: baseline data from the HOLISTIC study.
- Published in:
- Supportive Care in Cancer, 2025, v. 33, n. 3, p. 1, doi. 10.1007/s00520-025-09248-5
- By:
- Publication type:
- Article
Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 4, p. 353, doi. 10.1007/s00280-023-04615-7
- By:
- Publication type:
- Article
Predictive factors for toxicity and survival of second-line sunitinib in advanced gastrointestinal stromal tumours (GIST).
- Published in:
- Acta Oncologica, 2019, v. 58, n. 11, p. 1648, doi. 10.1080/0284186X.2019.1637017
- By:
- Publication type:
- Article
Capecitabine, irinotecan (CAPIRI) and sunitinib in metastatic colorectal cancer.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroups.
- Published in:
- Immunologic Research, 2022, v. 70, n. 2, p. 256, doi. 10.1007/s12026-021-09259-4
- By:
- Publication type:
- Article
A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia.
- Published in:
- Clinical & Experimental Immunology, 2009, v. 156, n. 3, p. 434, doi. 10.1111/j.1365-2249.2009.03909.x
- By:
- Publication type:
- Article